Dicerna Pharmaceuticals, Inc., an RNA interference company developing novel therapeutics in multiple disease areas, today announced that Bob D. Brown, Ph.D., senior vice president of research, Dicerna, and Dicerna co-fou...
National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation, and Silicon Kinetics, Inc., a San Diego-based biotechnology company with research la...
Two teams of scientists from Harvard-MIT Division of Health Science and Technology (HST) at Brigham and Women's Hospital have developed a new self-assembling hydrogel drug delivery system that is biocompatible, effic...
Applied Biosystems Inc., today announced that it has commercialized a new analysis system to enable researchers to perform high-sample-throughput genotyping studies that are faster, easier and more cost effective than ot...
Scientists from three Chicago-area universities have joined forces to develop new ways of building state-of-the-art chemical libraries that will help identify new compounds for future drug development and basic biomedical research.
Researchers are on the verge of unleashing the power of the element boron in a new generation of drugs and therapies, as decades of research begins to bear fruit. Boron has to date far been one of biology's best kept...
Despite the fact that proton therapy has been around for years, it is still a relatively uncommon way to treat cancer. Currently there are only five operating proton therapy clinics in the United States -- one each in Bo...
Over the last 10 years, researchers and clinicians have begun to use microelectromechanical systems (MEMS), which combine electronics technology with tiny mechanical devices like sensors and valves embedded in semiconduc...
Just as the perfect picture of a horse cannot convey the fluidity of it gallop, so does a frozen picture of DNA fail in describing its intricate dance. "These are wet, warm, squishy things," says Adam Cohen of Harvard University. They jiggle, they flap, they twist, they turn, and they randomly "walk" about.
Millipore Corporation, a Life Science leader providing technologies, tools, and services for bioscience research and biopharmaceutical manufacturing, today announced the release of a unique cell culture medium for generating three-dimensional, in vivo-like, epidermal keratinocyte models.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.